Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Image-Based Multiplex Immune Profiling of Cancer Tissues: Translational Implications. a Report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer Publisher Pubmed



Jahangir CA1 ; Page DB2 ; Broeckx G3, 4 ; Gonzalez CA1 ; Burke C1 ; Murphy C1 ; Reisfilho JS5 ; Ly A6 ; Harms PW7 ; Gupta RR8 ; Vieth M9 ; Hida AI10 ; Kahila M11 ; Kos Z12 Show All Authors
Authors
  1. Jahangir CA1
  2. Page DB2
  3. Broeckx G3, 4
  4. Gonzalez CA1
  5. Burke C1
  6. Murphy C1
  7. Reisfilho JS5
  8. Ly A6
  9. Harms PW7
  10. Gupta RR8
  11. Vieth M9
  12. Hida AI10
  13. Kahila M11
  14. Kos Z12
  15. Van Diest PJ13, 14
  16. Verbandt S15
  17. Thagaard J16, 17
  18. Khiroya R18
  19. Abduljabbar K19
  20. Acosta Haab G20
  21. Acs B21, 22
  22. Adams S23, 24
  23. Almeida JS25
  24. Alvaradocabrero I26
  25. Azmoudehardalan F27
  26. Badve S28
  27. Baharun NB29
  28. Bellolio ER30
  29. Bheemaraju V31
  30. Blenman KRM32, 33
  31. Botinelly Mendonca Fujimoto L34
  32. Burgues O35
  33. Chardas A36
  34. Cheang MCU37
  35. Ciompi F38
  36. Cooper LAD39
  37. Coosemans A40
  38. Corredor G41
  39. Dantas Portela FL42
  40. Deman F3
  41. Demaria S43, 44
  42. Dudgeon SN45
  43. Elghazawy M46, 47
  44. Fernandezmartin C48
  45. Fineberg S49
  46. Fox SB50
  47. Giltnane JM51
  48. Gnjatic S52
  49. Gonzalezericsson PI53
  50. Grigoriadis A54, 55
  51. Halama N56
  52. Hanna MG57
  53. Harbhajanka A58
  54. Hart SN59
  55. Hartman J22, 60
  56. Hewitt S61
  57. Horlings HM62
  58. Husain Z63
  59. Irshad S64
  60. Janssen EAM65, 66
  61. Kataoka TR67
  62. Kawaguchi K68
  63. Khramtsov AI69
  64. Kiraz U65, 66
  65. Kirtani P70
  66. Kodach LL71
  67. Korski K72
  68. Akturk G73
  69. Scott E74
  70. Kovacs A75, 76
  71. Laenkholm AV77, 78
  72. Langschwarz C9
  73. Larsimont D79
  74. Lennerz JK80
  75. Lerousseau M81, 82, 83
  76. Li X84
  77. Madabhushi A85
  78. Maley SK86
  79. Manur Narasimhamurthy V87
  80. Marks DK23
  81. Mcdonald ES88
  82. Mehrotra R89, 90
  83. Michiels S91
  84. Kharidehal D92
  85. Minhas FUAA93
  86. Mittal S94
  87. Moore DA95
  88. Mushtaq S96
  89. Nighat H97
  90. Papathomas T98, 99
  91. Penaultllorca F100
  92. Perera RD101, 102
  93. Pinard CJ103, 104, 105, 106
  94. Pintocardenas JC107
  95. Pruneri G108, 109
  96. Pusztai L110, 111
  97. Rajpoot NM112
  98. Rapoport BL113, 114
  99. Rau TT115
  100. Ribeiro JM116
  101. Rimm D117, 118
  102. Vincentsalomon A119
  103. Saltz J120
  104. Sayed S121
  105. Hytopoulos E121, 122
  106. Mahon S123
  107. Siziopikou KP124
  108. Sotiriou C125, 126
  109. Stenzinger A127
  110. Sughayer MA128
  111. Sur D129
  112. Symmans F130
  113. Tanaka S131
  114. Taxter T132
  115. Tejpar S15
  116. Teuwen J133
  117. Thompson EA134
  118. Tramm T135
  119. Tran WT136
  120. Van Der Laak J37
  121. Verghese GE54, 55
  122. Viale G137
  123. Wahab N138
  124. Walter T81, 82, 83
  125. Waumans Y139
  126. Wen HY57
  127. Yang W140
  128. Yuan Y141
  129. Bartlett J142
  130. Loibl S143
  131. Denkert C144
  132. Savas P102, 145
  133. Loi S102, 146
  134. Specht Stovgaard E147
  135. Salgado R3, 102
  136. Gallagher WM1
  137. Rahman A148

Source: Journal of Pathology Published:2024


Abstract

Recent advances in the field of immuno-oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has been found to have key value in predicting disease prognosis and treatment response in various cancers. Multiplex immunohistochemistry and immunofluorescence have emerged as potent tools for the simultaneous detection of multiple protein biomarkers in a single tissue section, thereby expanding opportunities for molecular and immune profiling while preserving tissue samples. By establishing the phenotype of individual tumour cells when distributed within a mixed cell population, the identification of clinically relevant biomarkers with high-throughput multiplex immunophenotyping of tumour samples has great potential to guide appropriate treatment choices. Moreover, the emergence of novel multi-marker imaging approaches can now provide unprecedented insights into the tumour microenvironment, including the potential interplay between various cell types. However, there are significant challenges to widespread integration of these technologies in daily research and clinical practice. This review addresses the challenges and potential solutions within a structured framework of action from a regulatory and clinical trial perspective. New developments within the field of immunophenotyping using multiplexed tissue imaging platforms and associated digital pathology are also described, with a specific focus on translational implications across different subtypes of cancer. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Other Related Docs
6. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
11. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
13. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
18. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)